NCT00006421View on ClinicalTrials.gov

Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 25, 2000

Conditions
Breast Cancer
Interventions
DRUG

2-Fluorodeoxyglucose

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00006421 - Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study | Biotech Hunter | Biotech Hunter